An epidemic caused by measles virus type D6 in Turkey

Turkish Journal of Pediatrics

Volumn 47, Issue 4, 2005, Pages 309-315

  Ceylan, Ali ^a   Ertem, Melikşah ^a   Korukluoǧlu, Gülay ^b   Acemoǧlu, Hamit ^a   Kara, Ismail Hamdi ^a   Erten, Pakize Gamze ^a   Arslan, Cem ^c   Ay, Mehmet Emin ^d  

^a DICLE UNIVERSITY   (Turkey)

^b Virology and NIC of Turkey Refik Saydam Hygiene Institute   (Turkey)

^c Cizre Health Center   (Turkey)

^d Idil Health Group   (Turkey)

Author keywords

Developing country; Immunization; Infant; Measles; Outbreak

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEASLES VACCINE;

AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; INFANT; INFECTION CONTROL; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; POPULATION DISTRIBUTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC); VIRUS ISOLATION;

CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; MEASLES; MEASLES VIRUS; TURKEY;

EID: 31344449303     PISSN: 00414301     EISSN: 00414301     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. World Health Organization. Global measles mortality reduction and regional elimination, 2000-2001. Weekly Epidemiological Record 2002; 77: 49-56 (http://www.who.int/wer).
2. Canadian Medical Association s Clinical Practice Guidelines Infobase. Measles Surveillance: Guidelines for Laboratory Support (1999). (http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ccdr-rmtc/99vol25/ dr2524ea.html).
3. Schlereth B, Rose JK, Buonocore L, ter Meulen V, Niewiesk S. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J Virol 2000; 74: 4652-4657.
4. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990; 162: 1036-1042.
5. Sato, H, Albrecht P, Reynolds DW, Stagno S, Ennis FA. Transfer of measles, mumps and rubella antibodies from mother to infant. Its effect on measles, mumps and rubella immunization. Am J Dis Child 1979; 133: 1240-1243.
6. Schoub BD, Johnson S, McAnerney JM, et al. Measles, mumps and rubella immunisation at nine months in a developing country. Ped Infect Dis J 1990; 9: 263-267.
7. WHO: Measles Technical Working Group. strategies for measles control and elimination (Report of a meeting, Geneva, 11-12 May 2000), Department of Vaccines and Biologicals, Geneva, 2001.
8. Expanded on Immunization: The immunological basis for immunization. Module 7: Measles; WHO documents. Geneva, WHO/EPI/GEN/93.17.
9. National Health Politics. Turkish Ministry of Health, Ankara, Mardi 1993.
10. Metz EC. Turkey: a country study. Federal Research Division, Library of Congress. International Development Network Information Resources for Sustainable Development, January 1995, (http:/lcweb2.loc.gov/cgibin/query/r?frd/cstdy:φield(DOCID+tr0060).
11. CDC. Global Laboratory Network for Measles Surveillance from (http://www.cdc.gov/ncidod/dvrd/revb/measles/intl_geno_rslt.htm).
12. Ertem M, Saka G, Ceylan A, Bilici M, Ilçin E. Diyarbakir Şehitlik Saǧlik Ocaǧi Bölgesinde Görfülen Kizamik Olgularinin Deǧerlendirilmesi. V. National Public Health Congress, Abstract Books, 12-16 October 1996, Istanbul, 544-547.
13. WHO Guidelines for Epidemic Preparedness and Response to Measles Outbreaks. Geneva, Switzerland, May 1999, WHO/CDS/CSR/ISR/99.1
14. World Health Organization-Global programme for vaccines and immunization, Using surveillance data and outbreak investigations to strengthen measles immunization programmes. Geneva, WHO/EPI/GEN/96.02.
15. Cutts FT. The immunological basis for immunization: Module 7: Measles. Global Programme for Vaccines and Immunization/World Health Organization, Geneva, 1993. WHO/EPL/GEN/95.03 Rev.2.
16. Ellidokuz H, Göktemen A, Uraz H, Aksakoǧlu G. Güzelbahçe Saǧlik ocaǧi bölgesinde kizamik salgini incelemesi. IV. National Public Health Congress, Abstract Books, 12-16 September 1994, Didim, 576-578.
17. Mutlu Ş, Fidaner C. Izmir'de kizamiǧin seyri. IV. National Public Health Congress, Abstract Books, 12-16 September 1994, Didim, 583-590.
18. Aylward RB, Clements J, Olivé JM. The impact of immunization control activities on measles outbreaks in middle and low income countries. Int J Epidemiol 1997: 26: 662-669.
19. Izurieta H, Brana M, Carrasco P, et al. Outbreak of Measles - Venezuela and Colombia, 2001-2002. MMWR 2002; 51: 757-760.
20. Pan American Health Organization. Progress toward interrupting indigenous measles transmission-Region of the Americas, Jan 1999-Sep 2000. MMWR 2000; 49: 986-990.
21. CDC. Progress toward interrupting indigenous measles transmissmion-Region of the Americas, Jan-Nov 2001. MMWR 2001; 50: 1133.
22. Pan American Health Organization, Division of Vaccines and Immunization. Haiti begins all out effort to halt measles and OPV-derived polio outbreaks. EPI Newsletter 2001; 22: 2.
23. Oliveira MI, Rota PA, Curti SP, et al. Genetic homogeneity of measles viruses associated with a measles outbreak, São Paulo, Brazil, 1997. Emerg Infect Dis 2002; 8: 808-813.
24. Hutchins S, Markowitz L, Atkinson W, Swint E, Hadler S. Measles outbreaks in the United States, 1987 through 1990. Pediatr Infect Dis J 1996; 15: 31-38.